Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Matilainen

Showing results (1-10 of 50) with videos related to

Pageof 5
Sort By:
Journal of Time Series Analysis|June 9, 2020
Extracting Conditionally Heteroskedastic Components using Independent Component AnalysisJari Miettinen, Markus Matilainen, Klaus Nordhausen, et al.
Wiley Interdisciplinary Reviews. Computational Statistics|October 17, 2022
A review of second-order blind identification methodsYan Pan, Markus Matilainen, Sara Taskinen, et al.
Acta Orthopaedica|July 17, 2024
Regional variations in incidence and treatment trends of Achilles tendon ruptures in Finland: a nationwide studyMarjukka Hallinen, Henri Sallinen, Heli Keskinen, et al.
Scandinavian Journal of Surgery : SJS : Official Organ for the Finnish Surgical Society and the Scandinavian Surgical Society|November 10, 2025
A nationwide comparison of public and private treatment of Achilles tendon rupture in FinlandMarjukka Hallinen, Oskari Leino, Inari Laaksonen, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|June 22, 2023
TSPO-Detectable Chronic Active Lesions Predict Disease Progression in Multiple SclerosisEero Polvinen, Markus Matilainen, Marjo Nylund, et al.
Journal of Neurology|December 28, 2022
PET-measurable innate immune cell activation reduction in chronic active lesions in PPMS brain after rituximab treatment: a case reportJussi Lehto, Marcus Sucksdorff, Marjo Nylund, et al.
Brain Communications|January 7, 2022
Phenotyping of multiple sclerosis lesions according to innate immune cell activation using 18 kDa translocator protein-PETMarjo Nylund, Marcus Sucksdorff, Markus Matilainen, et al.
Multiple Sclerosis and Related Disorders|October 15, 2020
Frequency and etiology of acute transverse myelitis in Southern FinlandEmma Smith, Nina Jaakonmäki, Marjo Nylund, et al.
Multiple Sclerosis and Related Disorders|February 18, 2020
Rituximab in the treatment of multiple sclerosis in the Hospital District of Southwest FinlandLaura Airas, Marjo Nylund, Iina Mannonen, et al.
International Journal of Environmental Research and Public Health|April 5, 2016
Modeling Associations between Principals' Reported Indoor Environmental Quality and Students' Self-Reported Respiratory Health Outcomes Using GLMM and ZIP ModelsOluyemi Toyinbo, Markus Matilainen, Mari Turunen, et al.
Pageof 5

Showing results (1-10 of 50) with videos related to

Sort By:
Pageof 5
Journal of Time Series Analysis|June 9, 2020
Extracting Conditionally Heteroskedastic Components using Independent Component AnalysisJari Miettinen, Markus Matilainen, Klaus Nordhausen, et al.
Wiley Interdisciplinary Reviews. Computational Statistics|October 17, 2022
A review of second-order blind identification methodsYan Pan, Markus Matilainen, Sara Taskinen, et al.
Acta Orthopaedica|July 17, 2024
Regional variations in incidence and treatment trends of Achilles tendon ruptures in Finland: a nationwide studyMarjukka Hallinen, Henri Sallinen, Heli Keskinen, et al.
Scandinavian Journal of Surgery : SJS : Official Organ for the Finnish Surgical Society and the Scandinavian Surgical Society|November 10, 2025
A nationwide comparison of public and private treatment of Achilles tendon rupture in FinlandMarjukka Hallinen, Oskari Leino, Inari Laaksonen, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|June 22, 2023
TSPO-Detectable Chronic Active Lesions Predict Disease Progression in Multiple SclerosisEero Polvinen, Markus Matilainen, Marjo Nylund, et al.
Journal of Neurology|December 28, 2022
PET-measurable innate immune cell activation reduction in chronic active lesions in PPMS brain after rituximab treatment: a case reportJussi Lehto, Marcus Sucksdorff, Marjo Nylund, et al.
Brain Communications|January 7, 2022
Phenotyping of multiple sclerosis lesions according to innate immune cell activation using 18 kDa translocator protein-PETMarjo Nylund, Marcus Sucksdorff, Markus Matilainen, et al.
Multiple Sclerosis and Related Disorders|October 15, 2020
Frequency and etiology of acute transverse myelitis in Southern FinlandEmma Smith, Nina Jaakonmäki, Marjo Nylund, et al.
Multiple Sclerosis and Related Disorders|February 18, 2020
Rituximab in the treatment of multiple sclerosis in the Hospital District of Southwest FinlandLaura Airas, Marjo Nylund, Iina Mannonen, et al.
International Journal of Environmental Research and Public Health|April 5, 2016
Modeling Associations between Principals' Reported Indoor Environmental Quality and Students' Self-Reported Respiratory Health Outcomes Using GLMM and ZIP ModelsOluyemi Toyinbo, Markus Matilainen, Mari Turunen, et al.
Pageof 5